Uzbekistan requires comprehensive serialization of pharmaceutical products, with each unit receiving a unique Data Matrix code containing GTIN, serial number, verification key, and crypto code. This digital identifier enables precise tracking from production or import through to final retail sale, creating an unbreakable chain of custody that protects against counterfeit medicines and ensures product authenticity throughout the distribution network.

The regulatory framework mandates that all pharmaceutical labels include both machine-readable Data Matrix codes and human-readable information in the Uzbek language, particularly for imported products. Labels must display essential data including GTIN, serial number, expiry date, and batch/lot number, ensuring that both automated systems and healthcare professionals can access critical product information for patient safety and regulatory compliance.

Uzbekistan enforces sophisticated aggregation rules requiring consumer units to be grouped into cartons and transport packaging, with each level identified through serialized shipping container codes (SSCC). This hierarchical system maintains complete parent-child packaging relationships documented within the ASL BELGISI platform, enabling full supply chain visibility without requiring the opening of aggregated shipping containers during distribution and inspection processes.

All pharmaceutical market participants—including manufacturers, importers, distributors, and retailers—must register with and report to the centralized ASL BELGISI system. This national platform captures every critical event from code assignment and aggregation through shipments and final sales, providing regulatory authorities with real-time oversight capabilities and enabling rapid response to potential supply chain disruptions or security threats.